modelPiritramide_Mller2006_reference
Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.
Information
| name: | piritramide |
| ATC code: | N02AC03 |
| model: | one compartment, IV dosing (PK_1C) |
| source: | Müller C et al. 2006 |
| population: | newborns, infants, and young children in intensive care units |
| measured compound: | piritramide |
| review: | curated candidate |
| record page: | pharmacolibrary-docs |
Parameters as reported in the paper
| parameter | value | unit | meaning |
|---|---|---|---|
| elimination half-life | 702 | min | t1/2z |
| Cl(t) | 15.9 | ml/min | CL |
| Vd(ss) | 2.0 | l/kg | V |
About piritramide
Piritramide is a strong opioid painkiller used to treat moderate to severe pain, such as pain after surgery. It is not approved everywhere and has been withdrawn in some countries, but it remains in clinical use in parts of Europe, mainly in hospital settings.
Summary written by glm-5.3-flash from Wikidata Q416439 and the WHO ATC classification; not checked by a person.
Identity, molar mass and metabolites: Piritramide.
References
Müller C et al. (2006). Pharmacokinetics of piritramide in newborns, infants and young children in intensive care units. European journal of pediatrics 165(4):229–239. DOI:10.1007/s00431-005-0021-z PUBMED:16496200
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | Cl_ref | 2.65e-07 | Cl [m3/s] |
| Real | Vd_ref | 0.14 | Vd [m3] |
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.0009 | Volume of distribution per kg (default 0.9 L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 2.7777777777777776e-7 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1e-4 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Info › Therapeutic range (metadata, not used in equations) | |||
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | maximal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Info › Substance metadata | |||
| Modelica.Units.SI.MolarMass | MM (from PK_1C) | 0 | molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0) |
| Info › Substance metadata (not used in equations) | |||
| Pharmacolibrary.Types.Dose | LD50 (from PK_1C) | 0 | median lethal dose [mg/kg]; 0 = unknown |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models) |
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Müller_2006: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate